Literature DB >> 22075188

Pathology of primary and metastatic mucinous ovarian neoplasms.

Sarah Lam Shang Leen1, Naveena Singh.   

Abstract

Recent years have seen a dramatic change in the pathological approach to ovarian mucinous neoplasms. A substantial proportion of tumours previously considered to be ovarian primaries actually represent secondary ovarian involvement by tumours elsewhere in the body. Two major categories of tumour have completely disappeared from the diagnostic spectrum: ovarian 'borderline' mucinous tumour associated with pseudomyxoma peritonei, and widely disseminated mucinous carcinomas. The emergent picture of true ovarian primary carcinoma of pure mucinous morphology is that this is a rare malignancy that is low grade and low stage at presentation in the vast majority of cases, with a very low likelihood of aggressive clinical behaviour. A large volume of literature has appeared concerning the pathological distinction of primary from metastatic ovarian mucinous neoplasms in view of the dramatically different prognosis and treacherously similar morphology. Clinicopathological parameters useful in the distinction of primary from metastatic mucinous ovarian carcinomas are reviewed. Major features favouring metastases are bilaterality, size <10 cm, surface involvement, extensive intra-abdominal spread and an extensive infiltrative pattern with desmoplasia. Two morphological patterns essentially exclude ovarian origin: colloid and signet ring carcinomas. Features favouring primary ovarian origin are unilaterality, large size >12 cm, smooth external surface and association with other ovarian pathology. An admixture of benign, borderline and malignant patterns in the same tumour favour primary origin, but can be misleading as a 'maturation' pattern in metastases can result in the same appearance.

Entities:  

Mesh:

Year:  2011        PMID: 22075188     DOI: 10.1136/jclinpath-2011-200162

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  19 in total

Review 1.  [Morphology of secondary ovarian tumors and metastases].

Authors:  L-C Horn; J Einenkel; R Handzel; A K Höhn
Journal:  Pathologe       Date:  2014-07       Impact factor: 1.011

Review 2.  Prognostic biomarkers in endometrial and ovarian carcinoma.

Authors:  Xavier Matias-Guiu; Ben Davidson
Journal:  Virchows Arch       Date:  2014-02-07       Impact factor: 4.064

3.  An Unusual Evolution of Krukenberg Tumour: A Case Report.

Authors:  Claudio Spinelli; Concetta Liloia; Jessica Piscioneri; Clara Ugolini; Silvia Strambi
Journal:  J Clin Diagn Res       Date:  2016-10-01

4.  The challenge of diagnosing a malignancy metastatic to the ovary: clinicopathological characteristics vary and morphology can be different from that of the corresponding primary tumor.

Authors:  João Lobo; Bianca Machado; Renata Vieira; Carla Bartosch
Journal:  Virchows Arch       Date:  2016-10-18       Impact factor: 4.064

Review 5.  Essentials for Pathological Evaluation of Peritoneal Surface Malignancies and Synoptic Reporting of Cytoreductive Surgery Specimens-A review and evidence-based guide.

Authors:  Aditi Bhatt; Suniti Mishra; Loma Parikh; Sandeep Sheth; Imran Gorur
Journal:  Indian J Surg Oncol       Date:  2019-03-19

6.  A prognostic nomogram for women with primary ovarian signet-ring cell carcinoma.

Authors:  Xijuan Wang; Xiurong Ke; Junxia Min
Journal:  Ann Transl Med       Date:  2021-04

7.  Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in a woman with pseudomyxoma peritonei: A case report.

Authors:  Clemens B Tempfer; Wiebke Solass; Bernd Buerkle; Marc-André Reymond
Journal:  Gynecol Oncol Rep       Date:  2014-10-18

8.  Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.

Authors:  Se Ik Kim; Myong Cheol Lim; Jiwon Lim; Young Joo Won; Sang Soo Seo; Sokbom Kang; Sang Yoon Park
Journal:  J Gynecol Oncol       Date:  2015-12-01       Impact factor: 4.401

9.  Preoperative gemcitabine and oxaliplatin in a patient with ovarian metastasis from pancreatic cystadenocarcinoma.

Authors:  Mariacristina Di Marco; Silvia Vecchiarelli; Marina Macchini; Raffaele Pezzilli; Donatella Santini; Riccardo Casadei; Lucia Calculli; Sokol Sina; Riccardo Panzacchi; Claudio Ricci; Elisa Grassi; Francesco Minni; Guido Biasco
Journal:  Case Rep Gastroenterol       Date:  2012-08-01

10.  Optimizing Ventana chromogenic dual in-situ hybridization for mucinous epithelial ovarian cancer.

Authors:  Xinyun Li; Sung-Hock Chew; Wen-Yee Chay; Soo-Kim Lim-Tan; Liang-Kee Goh
Journal:  BMC Res Notes       Date:  2013-12-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.